Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Asset disposition
Director departure
Quarterly results
Auditor change
Acq. announced
Consulting agrmnt
Appointed director
Inv. presentation
|
|
LISATA THERAPEUTICS, INC. (CLBS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Mazzo David J (CEO) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,030 shares
@ $3.2, valued at
$3.3k
|
|
| 01/11/2023 |
4
| Ruoslahti Erkki (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/11/2023 |
4
| KLOSK STEVEN M (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/11/2023 |
4
| HENSON HEIDI (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/11/2023 |
4
| Flowers Cynthia Louise (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/11/2023 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/11/2023 |
4
| AZAB MOHAMMAD (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/11/2023 |
4
| Slack David W. (President & CBO) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 24,000 shares
@ $0
Paid exercise price by delivering 3,358 shares
@ $3, valued at
$10.1k
Granted 12,000 options to buy
@ $3, valued at
$36k
|
|
| 01/11/2023 |
4
| Mazzo David J (CEO) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 60,000 shares
@ $0
Paid exercise price by delivering 7,845 shares
@ $3, valued at
$23.5k
Paid exercise price by delivering 3,470 shares
@ $3.195, valued at
$11.1k
Granted 30,000 options to buy
@ $3, valued at
$90k
|
|
| 01/11/2023 |
4
| Buck Kristen K (EVP, R&D and CMO) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 18,000 shares
@ $0
Paid exercise price by delivering 2,147 shares
@ $3, valued at
$6.4k
Paid exercise price by delivering 512 shares
@ $3.195, valued at
$1.6k
Granted 9,000 options to buy
@ $3, valued at
$27k
|
|
| 09/16/2022 |
3
| Slack David W. (President & CBO) has filed a Form 3 on LISATA THERAPEUTICS, INC. |
| 09/16/2022 |
3
| Ruoslahti Erkki (Director) has filed a Form 3 on LISATA THERAPEUTICS, INC. |
| 09/16/2022 |
3
| HENSON HEIDI (Director) has filed a Form 3 on LISATA THERAPEUTICS, INC. |
| 09/16/2022 |
4
| AZAB MOHAMMAD (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 19,200 shares
@ $6.25, valued at
$120k
|
|
| 09/16/2022 |
3
| AZAB MOHAMMAD (Director) has filed a Form 3 on LISATA THERAPEUTICS, INC. |
| 09/02/2022 |
4
| Buck Kristen K (EVP, R&D and CMO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 58,000 shares
@ $0.5, valued at
$29k
Paid exercise price by delivering 25,183 shares
@ $0.5, valued at
$12.6k
Paid exercise price by delivering 44,776 shares
@ $0.5, valued at
$22.4k
|
|
| 09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2022 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Paid exercise price by delivering 6,471 shares
@ $0.8063, valued at
$5.2k
Paid exercise price by delivering 6,611 shares
@ $0.8204, valued at
$5.4k
|
|
| 01/18/2022 |
4
| Girolamo Todd C (CLO, SVP of Corp Dev) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Paid exercise price by delivering 2,563 shares
@ $0.8063, valued at
$2.1k
Paid exercise price by delivering 2,158 shares
@ $0.8204, valued at
$1.8k
|
|
| 01/12/2022 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 401,000 shares
@ $0
Paid exercise price by delivering 56,410 shares
@ $0.917, valued at
$51.7k
Paid exercise price by delivering 16,740 shares
@ $0.8651, valued at
$14.5k
Granted 200,000 options to buy
@ $0.917, valued at
$183.4k
|
|
| 01/12/2022 |
4
| Girolamo Todd C (CLO, SVP of Corp Dev) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 129,000 shares
@ $0
Paid exercise price by delivering 17,405 shares
@ $0.917, valued at
$16k
Paid exercise price by delivering 4,722 shares
@ $0.8651, valued at
$4.1k
Granted 65,000 options to buy
@ $0.917, valued at
$59.6k
|
|
| 01/12/2022 |
4
| Buck Kristen K (EVP, R&D and CMO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 64,500 shares
@ $0
Paid exercise price by delivering 7,694 shares
@ $0.917, valued at
$7.1k
Granted 32,500 options to buy
@ $0.917, valued at
$29.8k
|
|
| 01/12/2022 |
4
| Whitaker Anne Clem (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 01/12/2022 |
4
| TRABER PETER G (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 01/12/2022 |
4
| MYERS STEVEN S (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 01/12/2022 |
4
| KLOSK STEVEN M (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 01/12/2022 |
4
| Flowers Cynthia Louise (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 01/12/2022 |
4
| Davidson Michael H. (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 01/12/2022 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 12/10/2021 |
4
| MYERS STEVEN S (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Bought 33,785 shares
@ $0.8936, valued at
$30.2k
|
|
| 11/08/2021 |
3
| Girolamo Todd C (CLO, SVP of Corp Dev) has filed a Form 3 on CALADRIUS BIOSCIENCES, INC. |
| 09/03/2021 |
4
| Buck Kristen K (EVP, R&D and CMO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 312,500 shares
@ $0
Paid exercise price by delivering 50,103 shares
@ $1.28, valued at
$64.1k
Granted 1,137,915 options to buy
@ $1.28, valued at
$1.5M
|
|
| 09/03/2021 |
3
| Buck Kristen K (EVP, R&D and CMO) has filed a Form 3 on CALADRIUS BIOSCIENCES, INC. |
|
|
|